-+ 0.00%
-+ 0.00%
-+ 0.00%
Cube Pharmaceutical (003020.SZ) subsidiary's application for registration and marketing license for polyvinyl alcohol eye drops was accepted
Share
Listen to the news

Zhitong Finance App News, Cube Pharmaceutical (003020.SZ) issued an announcement. Recently, Hefei Norit Pharmaceutical Co., Ltd., a holding subsidiary of the company, received the “Notice of Acceptance” of the application for registration and marketing of polyvinyl alcohol eye drops issued by the State Drug Administration.

Polyvinyl alcohol eye drops can be used as a lubricant to prevent or treat irritating symptoms such as dry eyes, foreign body sensation, eye fatigue, etc., or improve dry eye symptoms. They are suitable for dry eyes, visual fatigue, and dry eyes caused by factors such as wearing contact lenses, prolonged eye use, and dry environment. The marketed products are Class B over-the-counter drugs (OTC). This application is a drug that replicates the original drug that has already been marketed in China, and an OTC declaration is made simultaneously.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.
What's Trending